Discontinued — last reported Q4 '25
Over 3 years (FY 2021 to FY 2025), Business Sale Proceeds shows a downward trend with a -15.1% CAGR.
An increase signals portfolio optimization or a strategic pivot, while a lack of proceeds suggests a stable, long-term asset base.
This metric represents the cash inflows received from the divestiture or sale of business segments, product lines, or su...
Occurs sporadically; peers often divest legacy segments to focus on high-margin innovation areas like continuous glucose monitoring or diagnostics.
cf_proceeds_from_sale_of_business| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $0.00 | -$5.00M | $13.00M | $0.00 | $1.00M | $0.00 | $0.00 | -$14.00M | $0.00 | $0.00 | $42.00M | -$103.00M | -$6.00M | $0.00 | $12.00M | $0.00 | $0.00 | $10.00M |
| QoQ Change | — | — | +360.0% | -100.0% | — | -100.0% | — | — | +100.0% | — | — | -345.2% | +94.2% | +100.0% | — | -100.0% | — | — |
| YoY Change | — | — | — | — | — | +100.0% | -100.0% | — | -100.0% | — | +400.0% | — | — | — | -71.4% | +100.0% | +100.0% | — |
We use cookies for analytics. See our Privacy and Cookie Policy.